Zobrazeno 1 - 10
of 12
pro vyhledávání: '"N. W. Hoffman"'
Publikováno v:
Journal of Neurophysiology. 75:931-939
1. The intrinsic electrical properties of human neocortical neurons were studied with current-clamp and single-electrode voltage-clamp techniques in slices obtained from children, aged 3 mo to 15 yr, undergoing surgical treatment of intractable epile
Autor:
N. W. Hoffman, N. M. Doherty
Publikováno v:
ChemInform. 22
Autor:
O. A. Ileperuma, T. E. Nappier, N. W. Hoffman, Ottavio Gandolfi, Mauro Ghedini, Giuliano Dolcetti, R. D. Feltham
Publikováno v:
Inorganic Syntheses, Volume 16
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1d1b18cb9a856546a6816db4fca5743
https://doi.org/10.1002/9780470132470.ch9
https://doi.org/10.1002/9780470132470.ch9
Publikováno v:
Inorganic Syntheses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2871577fd86536530b63496f2753e30d
https://doi.org/10.1002/9780470132432.ch2
https://doi.org/10.1002/9780470132432.ch2
Publikováno v:
The Journal of Physical Chemistry. 93:4598-4603
The reaction of CO with NH{sub 3} over preoxidized Rh/SiO{sub 2} has been studied by infrared spectroscopy to detect surface intermediates. Two of the surface species having infrared bands at 2172 and 2225 cm{sup {minus}1} have been identified as RhN
Publikováno v:
Inorganica Chimica Acta. 6:531-542
Oxidative addition reactions of complexes of the type M(NO)L 3 where M = Co, Rh, Ir, and L = tertiary phosphine are described. Nuclear magnetic resonance spectra of the starting complexes are consistent with C 3ν pseudo-tetrahedral structure in solu
Autor:
N. W. Hoffman, G. Dolcetti
Publikováno v:
Inorganica Chimica Acta. 9:269-303
Autor:
N. W. HOFFMAN, T. L. BROWN
Publikováno v:
Chemischer Informationsdienst. 9
Autor:
N. W. Hoffman
Publikováno v:
Chemischer Informationsdienst. 15
Publikováno v:
Cancer research. 44(2)
Aziridinylbenzoquinone is a quinone compound capable of penetrating the central nervous system. It has demonstrated activity against both intracranial and i.p. murine tumors and human tumor xenographs. We have conducted a Phase I trial of aziridinylb